Teams

Imagine's Offers

The database may not be exhaustive, please do not hesitate to contact us !
  • in progress

    Nephronophthisis (NPH)
    Genotype Phenotype
    Targets
    Therapeutics
    Clinical trials
  • in progress

    Heterotaxia
    Genotype Phenotype
    Targets
    • In vivo models

      Ift20 inactivation (KO & conditional KO mouse models)

      Nodal inactivation (conditional KO mouse model)

    Therapeutics
    Clinical trials
    Situs invertus
    Genotype Phenotype
    • Cohorts

      Please contact us

    Targets
    Therapeutics
    Clinical trials
  • in progress

  • in progress

    Joubert syndrome (JS)
    Genotype Phenotype
    Targets
    Therapeutics
    Clinical trials
    Meckel syndrome (MKS)
    Genotype Phenotype
    Targets
    Therapeutics
    Clinical trials
    Hydrolethalus syndrome (HLS)
    Genotype Phenotype
    Targets
    Therapeutics
    Clinical trials
    Corpus Callosum malformations
    Genotype Phenotype
    Targets
    Therapeutics
    Clinical trials
    Malformations of cortical development
    Genotype Phenotype
    Targets
    Therapeutics
    Clinical trials
  • in progress

    Leber Congenital Amaurosis (LCA)
    Genotype Phenotype
    Targets
    Therapeutics
    Clinical trials
    X-linked retinitis pigmentosa (XLRP)
    Genotype Phenotype
    Targets
    Therapeutics
    Clinical trials

Contacts

  • Thibaut Perchet

    Thibaut PERCHET

    Business development manager

    • thibaut.perchet@institutimagine.org
    • +33 1 42 75 42 55

Our founding members

Our campuses

Our labels